NCT03426696 is a clinical trial of psychological condition in Thyroid Related Eye Disease, sponsored by Huijing Ye.

Who is sponsoring NCT03426696?

NCT03426696 is sponsored by Huijing Ye.

What drugs are being tested in NCT03426696?

Interventions in NCT03426696: psychological condition.

What condition does NCT03426696 study?

NCT03426696 studies Thyroid Related Eye Disease.

Is NCT03426696 still recruiting?

NCT03426696 is currently completed. Last updated 21 May 2020.

Last reviewed 2020-05-21 · How we verify

NCT03426696

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Psychological Status and Related Factors of Thyroid Related Eye Disease

Completed Last updated 21 May 2020

What this trial tests

trial testing psychological condition in Thyroid Related Eye Disease in 300 participants. Completed in 31 December 2018.

Timeline

1 December 2017

Primary endpoint
1 December 2018

31 December 2018

Quick facts

Lead sponsor	Huijing Ye
Status	Completed
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 December 2017
Primary completion	1 December 2018
Estimated completion	31 December 2018
Sites	1 location across China

Drugs / interventions tested

psychological condition

Conditions studied

Thyroid Related Eye Disease — all drugs for Thyroid Related Eye Disease →

Sponsor

Huijing Ye

Who can join

16 and older, any sex, with Thyroid Related Eye Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the psychological status of Thyroid Related Eye Disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03426696 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Huijing Ye
Last refreshed: 21 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03426696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing